ID   PLF2
AC   CVCL_VQ09
SY   PLF 2
DR   Wikidata; Q98128634
RX   PubMed=8618233;
RX   PubMed=21863025;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ08 ! PLF1
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
RX   PubMed=8618233; DOI=10.1093/jnci/88.7.419;
RA   Leonetti C., D'Agnano I., Lozupone F., Valentini A., Geiser T.,
RA   Zon G., Calabretta B., Citro G., Zupi G.;
RT   "Antitumor effect of c-myc antisense phosphorothioate
RT   oligodeoxynucleotides on human melanoma cells in vitro and and in
RT   mice.";
RL   J. Natl. Cancer Inst. 88:419-429(1996).
//
RX   PubMed=21863025; DOI=10.1038/bjc.2011.324; PMCID=PMC3185940;
RA   De Luca A., Lamura L., Strizzi L., Roma C., D'Antonio A.,
RA   Margaryan N.V., Pirozzi G., Hsu M.-Y., Botti G., Mari E., Hendrix M.J.C.,
RA   Salomon D.S., Normanno N.;
RT   "Expression and functional role of CRIPTO-1 in cutaneous melanoma.";
RL   Br. J. Cancer 105:1030-1038(2011).
//